These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17762885)

  • 1. Stimulating the development of mechanism-based, individualized pain therapies.
    Woodcock J; Witter J; Dionne RA
    Nat Rev Drug Discov; 2007 Sep; 6(9):703-10. PubMed ID: 17762885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can chronic arthritis pain teach about developing new analgesic drugs?
    Witter J; Dionne RA
    Arthritis Res Ther; 2004; 6(6):279-81. PubMed ID: 15535840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery and development of analgesics: new mechanisms, new modalities.
    Burgess G; Williams D
    J Clin Invest; 2010 Nov; 120(11):3753-9. PubMed ID: 21041957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repositioning: playing dirty to kill pain.
    Bastos LF; Coelho MM
    CNS Drugs; 2014 Jan; 28(1):45-61. PubMed ID: 24327258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerating the development of improved analgesic treatments: the ACTION public-private partnership.
    Dworkin RH; Turk DC
    Pain Med; 2011 Jul; 12 Suppl 3():S109-17. PubMed ID: 21752182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mechanisms have been tested in pain--how can we improve the chances of success?
    Hayes AG; Arendt-Nielsen L; Tate S
    Curr Opin Pharmacol; 2014 Feb; 14():11-7. PubMed ID: 24565006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapentadol (Nucynta)--a new analgesic.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):61-2. PubMed ID: 19661853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of new analgesics over the past 50 years: a lack of real breakthrough drugs.
    Kissin I
    Anesth Analg; 2010 Mar; 110(3):780-9. PubMed ID: 20185657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the pharmacotherapy of cancer pain.
    Mercadante S
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):487-94. PubMed ID: 12113115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert opinion on emerging drugs: chronic low back pain.
    Hsu E; Murphy S; Chang D; Cohen SP
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):103-27. PubMed ID: 25519435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the development of new pain treatments.
    Dickenson A
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):56-8. PubMed ID: 25643231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacologic basis of pain treatment].
    Tillement JP; Albengres E
    Therapie; 2001; 56(6):687-96. PubMed ID: 11878092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-opioid analgesics and co-analgesics in therapy of chronic pain].
    Gehling M; Niebergall H
    Z Arztl Fortbild Qualitatssich; 1998 Jan; 92(1):41-6. PubMed ID: 9553212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.
    Gunthorpe MJ; Chizh BA
    Drug Discov Today; 2009 Jan; 14(1-2):56-67. PubMed ID: 19063991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into pain-inducing and -related gene expression: a challenge for development of novel targeted therapeutic approaches.
    Vasileiou I; Giaginis C; Klonaris C; Theocharis S
    Fundam Clin Pharmacol; 2011 Feb; 25(1):48-62. PubMed ID: 20070377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of antalgic drugs].
    Dubray C
    Therapie; 1999; 54(1):135-45. PubMed ID: 10216437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics: the next generation of analgesic drugs?
    Chessell IP; Dudley A; Billinton A
    Drug Discov Today; 2012 Aug; 17(15-16):875-9. PubMed ID: 22464946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.